Necrotizing fasciitis is a rapidly progressive, life-threatening deep soft tissue infection that spreads along fascial planes, destroying subcutaneous tissue, fascia, and potentially muscle, with mortality rates of 20-40% even with optimal treatment. The infection is classified by microbiology: Type I (polymicrobial, most common) involves a synergistic mixture of aerobic and anaerobic organisms (streptococci, staphylococci, Enterobacteriaceae, Bacteroides, Clostridium) typically occurring in immunocompromised or post-surgical patients; Type II (monomicrobial) is caused by Group A Streptococcus (Streptococcus pyogenes) alone, often in previously healthy individuals, and is associated with streptococcal toxic shock syndrome from superantigen production (SPE-A, SPE-B). The pathophysiology involves bacterial enzymes (hyaluronidases, lipases, streptokinases) that dissolve fascial barriers, enabling rapid lateral spread. Thrombosis of nutrient blood vessels within the fascial planes causes ischemic necrosis, creating an anaerobic environment that further promotes bacterial proliferation. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score uses six laboratory parameters — CRP (greater than 15.00 mg/dL = 4 points), WBC (greater than 25,000 = 2 points), hemoglobin (less than 11 g/dL = 2 points), sodium (less than 135 mEq/L = 2 points), creatinine (greater than 1.6...